• 2021
  Rossignol T, Znaidi S, Chauvel M, Wesgate R, Decourty L, Menard-Szczebara F, Cupferman S, Dalko-Sciba M, Barnes R, Maillard JY, Saveanu C, d'Enfert C, , Ethylzingerone, a Novel Compound with Antifungal Activity., Antimicrob Agents Chemother 2021 03; 65(4): .
• 2021
  Marton T, Chauvel M, Feri A, Maufrais C, D'enfert C, Legrand M, , Factors that influence bidirectional long-tract homozygosis due to double-strand break repair in Candida albicans., Genetics 2021 Mar; (): .
• 2020
  Delarze E, Brandt L, Trachsel E, Patxot M, Pralong C, Maranzano F, Chauvel M, Legrand M, Znaidi S, Bougnoux ME, d'Enfert C, Sanglard D, , Identification and Characterization of Mediators of Fluconazole Tolerance in Candida albicans., Front Microbiol 2020 ; 11(): 591140.
• 2018
  Legrand M, Bachellier-Bassi S, Lee KK, Chaudhari Y, Tournu H, Arbogast L, Boyer H, Chauvel M, Cabral V, Maufrais C, Nesseir A, Maslanka I, Permal E, Rossignol T, Walker LA, Zeidler U, Znaidi S, Schoeters F, Majgier C, Julien RA, Ma L, Tichit M, Bouchier C, Van Dijck P, Munro CA, d'Enfert C, , Generating genomic platforms to study Candida albicans pathogenesis., Nucleic Acids Res 2018 08; 46(14): 6935-6949.
• 2017
  Khandelwal NK, Chauhan N, Sarkar P, Esquivel BD, Coccetti P, Singh A, Coste AT, Gupta M, Sanglard D, White TC, Chauvel M, d'Enfert C, Chattopadhyay A, Gaur NA, Mondal AK, Prasad R, Azole resistance in a mutant lacking the ABC transporter depends on TOR signaling, J. Biol. Chem. 2018 Jan;293(2):412-432.
• 2017
  Mietton F, Ferri E, Champleboux M, Zala N, Maubon D, Zhou Y, Harbut M, Spittler D, Garnaud C, Courçon M, Chauvel M, d'Enfert C, Kashemirov BA, Hull M, Cornet M, McKenna CE, Govin J, Petosa C, Selective BET bromodomain inhibition as an antifungal therapeutic strategy, Nat Commun 2017 May;8:15482.
• 2014
  Schwarzmüller T, Ma B, Hiller E, Istel F, Tscherner M, Brunke S, Ames L, Firon A, Green B, Cabral V, Marcet-Houben M, Jacobsen ID, Quintin J, Seider K, Frohner I, Glaser W, Jungwirth H, Bachellier-Bassi S, Chauvel M, Zeidler U, Ferrandon D, Gabaldón T, Hube B, d'Enfert C, Rupp S, Cormack B, Haynes K, Kuchler K, Systematic phenotyping of a large-scale Candida glabrata deletion collection reveals novel antifungal tolerance genes, PLoS Pathog. 2014 Jun;10(6):e1004211.
• 2013
  Monniot C, Boisramé A, Da Costa G, Chauvel M, Sautour M, Bougnoux ME, Bellon-Fontaine MN, Dalle F, d'Enfert C, Richard ML, Rbt1 protein domains analysis in Candida albicans brings insights into hyphal surface modifications and Rbt1 potential role during adhesion and biofilm formation, PLoS ONE 2013;8(12):e82395.
• 2013
  Znaidi S, Nesseir A, Chauvel M, Rossignol T, d'Enfert C, , A comprehensive functional portrait of two heat shock factor-type transcriptional regulators involved in Candida albicans morphogenesis and virulence., PLoS Pathog 2013 Aug; 9(8): e1003519.
• 2012
  Cabral V, Chauvel M, Firon A, Legrand M, Nesseir A, Bachellier-Bassi S, Chaudhari Y, Munro CA, d'Enfert C, Modular gene over-expression strategies for Candida albicans, Methods Mol. Biol. 2012;845:227-44.
• 2011
  Bonhomme J, Chauvel M, Goyard S, Roux P, Rossignol T, d'Enfert C, Contribution of the glycolytic flux and hypoxia adaptation to efficient biofilm formation by Candida albicans, Mol. Microbiol. 2011 May;80(4):995-1013.
• 2009
  Spiering MJ, Moran GP, Chauvel M, Maccallum DM, Higgins J, Hokamp K, Yeomans T, d'Enfert C, Coleman DC, Sullivan DJ, Comparative transcript profiling of Candida albicans and Candida dubliniensis identifies SFL2, a C. albicans gene required for virulence in a reconstituted epithelial infection model, Eukaryotic Cell 2010 Feb;9(2):251-65.
• 2006
  Ficca G, Chauvel M, de Moüy D,, [Prevalence of community-acquired methicillin-résistant Staphylococcus aureus], Med Mal Infect 2006 Apr;36(4):207-12.
• 1999
  Pangon B, Pina P, Gazagne L, Chauvel M, Godard T, Courvalin P, Allouch P, Antimicrobial susceptibility of 471 enterococcal strains responsible for infections at 101 French hospitals. Collège de Bactériologie, Virologie, Hygiène des Hôpitaux, Eur. J. Clin. Microbiol. Infect. Dis. 1999 Nov;18(11):836-8.
• 1999
  Van Bambeke F, Chauvel M, Reynolds PE, Fraimow HS, Courvalin P, Vancomycin-dependent Enterococcus faecalis clinical isolates and revertant mutants, Antimicrob. Agents Chemother. 1999 Jan;43(1):41-7.
• 1996
  Evers S, Casadewall B, Charles M, Dutka-Malen S, Galimand M, Courvalin P, Evolution of structure and substrate specificity in D-alanine:D-alanine ligases and related enzymes, J. Mol. Evol. 1996 Jun;42(6):706-12.
• 1995
  Dutka-Malen S, Charles M, Courvalin P, Evaluation of the BBLreg CrystalTM MRSA ID System for Rapid Detection of Methicillin Resistance in Staphylococcus aureus, Clin. Microbiol. Infect. 1995 Sep;1(1):50-53.